Micro-rna family that modulates fibrosis and uses thereof

Abstract

1 . A method of treating cardiac fibrosis, cardiac hypertrophy, or heart failure in a subject in need thereof comprising: (a) identifying a subject having cardiac fibrosis, cardiac hypertrophy or heart failure; and (b) administering to said subject an agonist of miR-29a-c expression or function. 2 .